Should I buy or sell Cochlear stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cochlear in the last year. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" CHEOY shares. View CHEOY analyst ratings or view top-rated stocks .

How have CHEOY shares performed in 2024?

Cochlear's stock was trading at $101.39 at the beginning of 2024. Since then, CHEOY shares have increased by 0.6% and is now trading at $101.96. View the best growth stocks for 2024 here .

Are investors shorting Cochlear?

Cochlear saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 2,100 shares, an increase of 200.0% from the March 15th total of 700 shares. Based on an average trading volume of 7,600 shares, the days-to-cover ratio is currently 0.3 days. View Cochlear's Short Interest .

How often does Cochlear pay dividends? What is the dividend yield for Cochlear?

Cochlear declared a dividend on Saturday, March 16th. Investors of record on Friday, March 22nd will be given a dividend of $0.0336 per share on Tuesday, April 30th. This represents a dividend yield of 1%. The ex-dividend date of this dividend is Thursday, March 21st. Read our dividend analysis for CHEOY .

Is Cochlear a good dividend stock?

Cochlear (OTCMKTS:CHEOY) pays an annual dividend of $1.16 per share and currently has a dividend yield of 1.13%. Read our dividend analysis for CHEOY .

How do I buy shares of Cochlear?

Shares of CHEOY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:CHEOY

Cochlear (CHEOY) Stock Price, News & Analysis

→ Strange new buyer driving up gold (From Stansberry Research) (Ad)

Free CHEOY Stock Alerts

$101.96

-0.66 (-0.64%)

(As of 04/18/2024 ET)

Compare

Today's Range: $101.89
▼
$102.51
50-Day Range: $98.91
▼
$114.50
52-Week Range: $73.73
▼
$114.50

Volume: 4,718 shs
Average Volume: 3,458 shs
Market Capitalization: $13.36 billion

P/E Ratio: N/A
Dividend Yield: 1.14%
Price Target: N/A

Stock Analysis Analyst Forecasts Chart Dividend Financials Headlines SEC Filings Short Interest

Get Cochlear alerts:

Ad Stansberry Research

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

But there's a much better move you can make to get in front of these big moves today.

About Cochlear Stock (OTCMKTS:CHEOY)

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

CHEOY Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CHEOY Stock News Headlines

April 3, 2024 | marketwatch.com

Cochlear's Oticon Implants Acquisition Approved by Australian Regulator

March 27, 2024 | afr.com

Can a vaccine slow down the Cochlear train?

April 19, 2024 | Stansberry Research (Ad)

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

March 20, 2024 | finance.yahoo.com

Cochlear Ltd's Dividend Analysis

February 28, 2024 | prnewswire.com

Cochlear calls for action in Washington D.C. ahead of World Hearing Day

February 25, 2024 | msn.com

Cochlear Limited - Depositary Receipt () (CHEOY) Price Target Increased by 11.05% to 94.91

February 22, 2024 | prnewswire.com

Cochlear announces 2024 winners of annual scholarships

February 19, 2024 | realmoney.thestreet.com

Cochlear price target raised by A$20 at UBS, here's why

April 19, 2024 | Stansberry Research (Ad)

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

February 19, 2024 | realmoney.thestreet.com

Cochlear price target raised by A$18 at Morgan Stanley, here's why

February 19, 2024 | afr.com

What we learnt from Cochlear, Wesptac, Ampol and Bendigo’s results

February 18, 2024 | markets.businessinsider.com

Citi Reaffirms Their Sell Rating on Cochlear Limited (CHEOF)

February 18, 2024 | msn.com

Cochlear's first-half profit up 35pct to $191 million

February 18, 2024 | fool.com.au

Cochlear share price falls despite 29% dividend boost

February 18, 2024 | marketwatch.com

Cochlear Hoists Dividend on 35% Jump in 1H Profit -- Update

February 18, 2024 | afr.com

Cochlear’s big first half delivers best dividend in a decade

February 16, 2024 | finance.yahoo.com

Cochlear Implant Market to Accumulate a Valuation of USD 4.0 Billion by 2030, Advancing at a 10.36% CAGR | MarketDigits

February 12, 2024 | markets.businessinsider.com

Morgans downgrades Cochlear Limited (CHEOF) to a Hold

February 9, 2024 | markets.businessinsider.com

Analysts Are Bullish on Top Healthcare Stocks: CSL (CMXHF), Cochlear Limited (CHEOF)

February 8, 2024 | afr.com

Cochlear lifts guidance despite threat of deafness drugs

February 7, 2024 | fool.com.au

Cochlear shares jump 6% on guidance upgrade

February 7, 2024 | marketwatch.com

Cochlear Shares Jump Amid Stronger-Than-Expected Implant Sales

February 6, 2024 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Incyte (INCY) and Cochlear Limited (OtherCHEOF)

January 25, 2024 | finance.yahoo.com

Global Cochlear Implants Market Report 2024: Market Forecast for 5 Regions and 17+ Countries, Company Profiles of the Top 10+ Major Market Players

November 27, 2023 | msn.com

Cochlear - ADR (CHEOY) Price Target Increased by 5.45% to 83.47

November 8, 2023 | markets.businessinsider.com

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Globus Medical (GMED) and Cochlear Limited (OtherCHEOF)

October 19, 2023 | benzinga.com

New Clinical Publication Reports First Three Patients in Early Feasibility Trial for Envoy Medical's Fully Implanted Cochlear Device

See More Headlines

Receive CHEOY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 4/30 Dividend: 3/21/2024
Today: 4/19/2024
Dividend Payable: 4/30/2024
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: N/A
Sub-Industry: N/A
Current Symbol: OTCMKTS:CHEOY
Previous Symbol: OTCMKTS:CHEOY
CUSIP: N/A
CIK: 1453930
Web: www.cochlear.com
Phone: (129) 428-6555
Fax: N/A
Employees: 4,800
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $1.32 billion
Price / Sales: 10.14
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 130,990,000
Free Float: N/A
Market Cap: $13.36 billion
Optionable: Not Optionable
Beta: 0.91

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. Diggory William Howitt BE (Hons) (Age 57)
MBA, CEO, MD, President & Executive Director
Comp: $3.12M
Mr. Stuart Sayers
Chief Financial Officer
Mr. Jan Janssen MSc Elec Eng (Age 59)
Chief Technology Officer
Comp: $1.33M
Ms. Karen O'Driscoll
Chief Information Officer
Ms. Kristina Devon
Vice President of Investor Relations
Rob McGrory
Group General Counsel
Ms. Jennifer Stevenson
VP of Corporate Communications & Brand
Mr. Dean Phizacklea
Senior Vice President of Global Strategic Marketing
Ms. Jennifer Hornery
Senior Vice President of Global People & Culture
Mr. Greg Bodkin BE (Hons)
MComm (UNSW), Senior Vice President of Global Supply Chain

Key Competitors

View All Competitors

CHEOY Stock Analysis - Frequently Asked Questions

Should I buy or sell Cochlear stock right now?: 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cochlear in the last year. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" CHEOY shares.
View CHEOY analyst ratings or view top-rated stocks.
How have CHEOY shares performed in 2024?: Cochlear's stock was trading at $101.39 at the beginning of 2024. Since then, CHEOY shares have increased by 0.6% and is now trading at $101.96.
View the best growth stocks for 2024 here.
Are investors shorting Cochlear?: Cochlear saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 2,100 shares, an increase of 200.0% from the March 15th total of 700 shares. Based on an average trading volume of 7,600 shares, the days-to-cover ratio is currently 0.3 days.
View Cochlear's Short Interest.
How often does Cochlear pay dividends? What is the dividend yield for Cochlear?: Cochlear declared a dividend on Saturday, March 16th. Investors of record on Friday, March 22nd will be given a dividend of $0.0336 per share on Tuesday, April 30th. This represents a dividend yield of 1%. The ex-dividend date of this dividend is Thursday, March 21st.
Read our dividend analysis for CHEOY.

Is Cochlear a good dividend stock?: Cochlear (OTCMKTS:CHEOY) pays an annual dividend of $1.16 per share and currently has a dividend yield of 1.13%.
Read our dividend analysis for CHEOY.
How do I buy shares of Cochlear?: Shares of CHEOY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CHEOY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Cochlear (CHEOY) Stock Price, News & Analysis

About Cochlear Stock (OTCMKTS:CHEOY)

CHEOY Stock Price History

CHEOY Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

CHEOY Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info